Your browser doesn't support javascript.
loading
Methylphenidate causes chronic eosinophilic pneumonia.
Alghamdi, Dhafer; Jahdali, Hamdan; Alharbi, Abdullah; Alshehri, Ahmad; Alfirm, Bandar; Bamefleh, Hanaa.
Afiliación
  • Alghamdi D; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Jahdali H; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alharbi A; Department of Pulmonology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alshehri A; Department of Psychiatry, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alfirm B; Department of Psychiatry, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Bamefleh H; Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Ann Thorac Med ; 19(1): 112-115, 2024.
Article en En | MEDLINE | ID: mdl-38444994
ABSTRACT
A man who is 38 years old and diagnosed with attention-deficit hyperactivity disorder was prescribed methylphenidate. Three weeks later, he began experiencing progressive shortness of breath and coughing. Imaging of his chest showed patchy bilateral ground-glass opacities, and bronchoscopy revealed a 15% eosinophil count in his bronchoalveolar lavage. A transbronchial biopsy confirmed a diagnosis of eosinophilic pneumonia. The patient's condition improved when he was given steroids and stopped taking methylphenidate. However, he developed the same symptoms again a few days after restarting the medication, along with a skin rash. This strongly suggests that methylphenidate was the cause of his eosinophilic pneumonia.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Thorac Med Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Thorac Med Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: India